S&P 500   3,344.41 (-0.14%)
DOW   27,305.70 (-0.30%)
QQQ   273.81 (-0.30%)
AAPL   452.59 (-0.66%)
MSFT   214.95 (-0.65%)
FB   275.70 (+3.93%)
GOOGL   1,512.50 (+0.50%)
AMZN   3,220.89 (-0.13%)
NVDA   455.92 (+0.55%)
CGC   17.13 (-2.23%)
BABA   255.90 (-3.68%)
TSLA   1,482.01 (-0.51%)
MU   48.73 (+0.06%)
GE   6.31 (-0.32%)
AMD   86.12 (-0.68%)
T   29.65 (-0.64%)
F   6.84 (-1.30%)
ACB   10.24 (-0.68%)
GILD   68.98 (+0.25%)
NFLX   501.74 (-1.44%)
DIS   131.65 (+0.63%)
BAC   25.43 (-0.16%)
BA   171.63 (-0.33%)
S&P 500   3,344.41 (-0.14%)
DOW   27,305.70 (-0.30%)
QQQ   273.81 (-0.30%)
AAPL   452.59 (-0.66%)
MSFT   214.95 (-0.65%)
FB   275.70 (+3.93%)
GOOGL   1,512.50 (+0.50%)
AMZN   3,220.89 (-0.13%)
NVDA   455.92 (+0.55%)
CGC   17.13 (-2.23%)
BABA   255.90 (-3.68%)
TSLA   1,482.01 (-0.51%)
MU   48.73 (+0.06%)
GE   6.31 (-0.32%)
AMD   86.12 (-0.68%)
T   29.65 (-0.64%)
F   6.84 (-1.30%)
ACB   10.24 (-0.68%)
GILD   68.98 (+0.25%)
NFLX   501.74 (-1.44%)
DIS   131.65 (+0.63%)
BAC   25.43 (-0.16%)
BA   171.63 (-0.33%)
S&P 500   3,344.41 (-0.14%)
DOW   27,305.70 (-0.30%)
QQQ   273.81 (-0.30%)
AAPL   452.59 (-0.66%)
MSFT   214.95 (-0.65%)
FB   275.70 (+3.93%)
GOOGL   1,512.50 (+0.50%)
AMZN   3,220.89 (-0.13%)
NVDA   455.92 (+0.55%)
CGC   17.13 (-2.23%)
BABA   255.90 (-3.68%)
TSLA   1,482.01 (-0.51%)
MU   48.73 (+0.06%)
GE   6.31 (-0.32%)
AMD   86.12 (-0.68%)
T   29.65 (-0.64%)
F   6.84 (-1.30%)
ACB   10.24 (-0.68%)
GILD   68.98 (+0.25%)
NFLX   501.74 (-1.44%)
DIS   131.65 (+0.63%)
BAC   25.43 (-0.16%)
BA   171.63 (-0.33%)
S&P 500   3,344.41 (-0.14%)
DOW   27,305.70 (-0.30%)
QQQ   273.81 (-0.30%)
AAPL   452.59 (-0.66%)
MSFT   214.95 (-0.65%)
FB   275.70 (+3.93%)
GOOGL   1,512.50 (+0.50%)
AMZN   3,220.89 (-0.13%)
NVDA   455.92 (+0.55%)
CGC   17.13 (-2.23%)
BABA   255.90 (-3.68%)
TSLA   1,482.01 (-0.51%)
MU   48.73 (+0.06%)
GE   6.31 (-0.32%)
AMD   86.12 (-0.68%)
T   29.65 (-0.64%)
F   6.84 (-1.30%)
ACB   10.24 (-0.68%)
GILD   68.98 (+0.25%)
NFLX   501.74 (-1.44%)
DIS   131.65 (+0.63%)
BAC   25.43 (-0.16%)
BA   171.63 (-0.33%)
Log in

NASDAQ:BMRABiomerica Stock Price, Forecast & News

$8.70
-0.17 (-1.92 %)
(As of 08/7/2020 11:32 AM ET)
Add
Compare
Today's Range
$8.66
Now: $8.70
$8.97
50-Day Range
$5.65
MA: $8.48
$12.04
52-Week Range
$2.05
Now: $8.70
$23.39
Volume6,539 shs
Average Volume1.05 million shs
Market Capitalization$102.23 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.71
Biomerica, Inc., together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The company's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. It primarily offers its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the point-of-care and in-hospital/clinical laboratories worldwide. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy, which is in clinical studies to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.13 out of 5 stars


Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BMRA
CUSIPN/A
Phone949-645-2111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.20 million
Book Value$0.41 per share

Profitability

Net Income$-2,390,000.00

Miscellaneous

Employees54
Market Cap$102.23 million
Next Earnings Date9/4/2020 (Estimated)
OptionableNot Optionable
$8.70
-0.17 (-1.92 %)
(As of 08/7/2020 11:32 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BMRA News and Ratings via Email

Sign-up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Biomerica (NASDAQ:BMRA) Frequently Asked Questions

How has Biomerica's stock been impacted by COVID-19 (Coronavirus)?

Biomerica's stock was trading at $2.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BMRA stock has increased by 200.0% and is now trading at $8.70.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Biomerica?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biomerica in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Biomerica
.

When is Biomerica's next earnings date?

Biomerica is scheduled to release its next quarterly earnings announcement on Friday, September 4th 2020.
View our earnings forecast for Biomerica
.

How were Biomerica's earnings last quarter?

Biomerica, Inc. (NASDAQ:BMRA) announced its quarterly earnings data on Tuesday, April, 14th. The company reported ($0.09) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.03. The firm earned $1.18 million during the quarter, compared to the consensus estimate of $1.35 million. Biomerica had a negative return on equity of 67.54% and a negative net margin of 51.37%.
View Biomerica's earnings history
.

What price target have analysts set for BMRA?

1 analysts have issued 12 month target prices for Biomerica's stock. Their forecasts range from $11.00 to $11.00. On average, they anticipate Biomerica's share price to reach $11.00 in the next year. This suggests a possible upside of 26.4% from the stock's current price.
View analysts' price targets for Biomerica
.

Has Biomerica been receiving favorable news coverage?

Headlines about BMRA stock have been trending positive this week, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Biomerica earned a daily sentiment score of 2.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term.
View the latest news about Biomerica
.

Are investors shorting Biomerica?

Biomerica saw a increase in short interest in July. As of July 31st, there was short interest totaling 587,700 shares, an increase of 19.5% from the July 15th total of 491,800 shares. Based on an average daily trading volume, of 865,800 shares, the days-to-cover ratio is currently 0.7 days. Approximately 6.6% of the shares of the stock are short sold.
View Biomerica's Current Options Chain
.

Who are some of Biomerica's key competitors?

What other stocks do shareholders of Biomerica own?

Who are Biomerica's key executives?

Biomerica's management team includes the following people:
  • Mr. Zackary S. Irani, Chairman & CEO (Age 53)
  • Ms. Janet Moore, CFO, Treasurer, Sec. & Director (Age 68)

What is Biomerica's stock symbol?

Biomerica trades on the NASDAQ under the ticker symbol "BMRA."

Who are Biomerica's major shareholders?

Biomerica's stock is owned by a variety of institutional and retail investors. Top institutional investors include Heritage Investors Management Corp (0.58%).
View institutional ownership trends for Biomerica
.

Which major investors are buying Biomerica stock?

BMRA stock was acquired by a variety of institutional investors in the last quarter, including Heritage Investors Management Corp.
View insider buying and selling activity for Biomerica
.

How do I buy shares of Biomerica?

Shares of BMRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Biomerica's stock price today?

One share of BMRA stock can currently be purchased for approximately $8.70.

How big of a company is Biomerica?

Biomerica has a market capitalization of $102.23 million and generates $5.20 million in revenue each year. The company earns $-2,390,000.00 in net income (profit) each year or ($0.26) on an earnings per share basis. Biomerica employs 54 workers across the globe.

What is Biomerica's official website?

The official website for Biomerica is www.biomerica.com.

How can I contact Biomerica?

Biomerica's mailing address is 17571 Von Karman Avenue, Irvine CA, 92614. The company can be reached via phone at 949-645-2111.

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.